Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia The IT-DIAfN Protocol

被引:0
|
作者
Galluzzi, Samantha [1 ]
Mega, Anna [1 ]
Di Fede, Giuseppe [3 ]
Muscio, Cristina [3 ]
Fascendini, Sara [4 ]
Benussi, Luisa [2 ]
Tagliavini, Fabrizio [5 ]
Frisoni, Giovanni B. [1 ,8 ,9 ]
Di Maria, Emilio [6 ,7 ]
机构
[1] IRCCS Ist Ctr San Gio Vannidio Fatebenefratelli, Lab Alzheimers Neuroimaging & Epidemiol, Brescia, Italy
[2] IRCCS Ist Ctr San Gio Vannidio Fatebenefratelli, Mol Markers Lab, Brescia, Italy
[3] Fdn IRCCS Ist Neurol Carlo Besta, Neurol 5, Neuropathol Unit, Milan, Italy
[4] FERB Alzheimer Ctr, Gazzaniga, Italy
[5] Fdn IRCCS Ist Neurol Carlo Besta, Sci Directorate, Milan, Italy
[6] Univ Genoa, Dept Hlth Sci, Via Pastore 1, I-16132 Genoa, Italy
[7] Galliera Hosp, Unit Med Genet, Via Pastore 1, I-16132 Genoa, Italy
[8] Univ Hosp, Dept Rehabil & Geriatr, Mem Clin, Geneva, Switzerland
[9] Univ Geneva, Geneva, Switzerland
来源
关键词
Alzheimer disease; frontotemporal dementia; genetic counseling; genetic testing; psychological outcomes; HUNTINGTONS-DISEASE; CONTROL BELIEFS; HEALTH LOCUS; ONSET; RISK;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim: Our aim was to evaluate the psychological impact of predictive genetic testing in individuals at-risk for inherited dementia who underwent a structured counseling and testing protocol. Methods: Participants were healthy at-risk relatives from families with at least one affected patient, in whom a disease-associated genetic variant had been ascertained. A comprehensive psychological assessment (personality, anxiety and depression, quality of life, coping strategies, resilience and health-related beliefs) was administered at baseline, at 6 months and 12 months follow-up. Results: Twenty-four participants from 13 families were included. Sixteen participants underwent blood sampling and genetic analysis; 6 resulted to be carriers of pathogenic variants (1 in PSEN1, 1 in PSEN2, 4 in GRN). Carriers showed higher score on the Resilience Scale for Adults (RSA) - social competence, and on Multidimensional Health Locus of Control - internal, than noncarriers (P= 0.03 for both). Ten atrisk relatives who completed the follow-up showed improvement in RSA - planned future (P= 0.01) with respect to baseline. Discussion: Our case series showed that at-risk individuals undergoing predictive testing showed benefit on personal life and no detrimental impact on a broad range of psychological outcomes. Higher social skills and lower internal health locus of control in carriers may be an early psychological correlate of preclinical dementia.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 50 条
  • [41] A personal view on reviewing the psychological consequences of predictive genetic testing for late onset disease
    Gerry Evers-Kiebooms
    European Journal of Human Genetics, 2001, 9 : 392 - 393
  • [42] Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease
    Amador, Maria Del Mar
    Gargiulo, Marcela
    Boucher, Christilla
    Herson, Ariane
    Staraci, Stephanie
    Salachas, Francois
    Clot, Fabienne
    Cazeneuve, Cecile
    Le Ber, Isabelle
    Durr, Alexandra
    NEUROLOGY-GENETICS, 2021, 7 (01)
  • [43] Genetic Algorithms for Optimized Diagnosis of Alzheimer's Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
    Diaz-Alvarez, Josefa
    Matias-Guiu, Jordi A.
    Cabrera-Martin, Maria Nieves
    Pytel, Vanesa
    Segovia-Rios, Ignacio
    Garcia-Gutierrez, Fernando
    Hernandez-Lorenzo, Laura
    Matias-Guiu, Jorge
    Carreras, Jose Luis
    Ayala, Jose L.
    Initiative, Alzheimer's Dis Neuroimaging
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 13
  • [44] Experiences of predictive genetic testing in inherited motor neuron disease: Findings from a qualitative interview study
    Howard, Jade
    Forrest Keenan, Karen
    Mazanderani, Fadhila
    Turner, Martin R.
    Locock, Louise
    JOURNAL OF GENETIC COUNSELING, 2025, 34 (01)
  • [45] Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease
    Kagawa, Yoshiyuki
    Yamamoto, Yoshiaki
    Ueno, Ayami
    Inomata, Kengo
    Tezuka, Mayu
    Osawa, Takashi
    Yazawa, Yasuharu
    Maeda, Toshio
    Obi, Tomokazu
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2021, 11 (03) : 264 - 272
  • [46] Differential impact of genetic and demographic variables on clinical course of dementia and Alzheimer's disease
    Lisota, R
    Tschanz, J
    Norton, M
    Corcoran, C
    Leslie, C
    Lyketsos, C
    Steinberg, M
    Breitner, J
    Welsh-Bohmer, K
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S152 - S153
  • [47] "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics
    Yang, Hyun Ju
    Kang, Na Ri
    Jung, Young Eun
    Kim, Moon Doo
    Jeong, Hyun Ghang
    Lee, Tae Jin
    Han, Ji Won
    Kim, Ki Woong
    Park, Joon Hyuk
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1253 - 1260
  • [48] Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease
    Skeehan, Katie
    Heaney, Christopher
    Cook-Deegan, Robert
    GENETICS IN MEDICINE, 2010, 12 (04) : S71 - S82
  • [49] Comparing the impact of susceptibility versus deterministic genetic testing for Alzheimer's disease
    Cassidy, MR
    Roberts, S
    Bird, T
    Steinbart, E
    Linnenbringer, E
    Cupples, A
    Green, RC
    NEUROLOGY, 2006, 66 (05) : 282 - 282
  • [50] A New Scale Measuring Psychologic Impact of Genetic Susceptibility Testing for Alzheimer Disease
    Chung, Winston W.
    Chen, Clara A.
    Cupples, L. Adrienne
    Roberts, J. Scott
    Hiraki, Susan C.
    Nair, Anil K.
    Green, Robert C.
    Stern, Robert A.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2009, 23 (01): : 50 - 56